In Every Issue
E-Media
E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES SoftWatch [...]
By
PharmaOutlet
Contributed by Merrill Matthews Jr., Ph.D. ANSWERING THE INDUSTRY’S CRITICS: PRICES [...]
By
Raise Your Voice: Letters
RAISE your voice LETTERS Asynchronous Discussions Online asynchronous discussions provide [...]
By
Letter from the Editor
PharmaVOICE THE FORUM FOR THE INDUSTRY EXECUTIVE Volume 3 . [...]
By Taren Grom, Editor
E-Media
E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES SoftWatch [...]
E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES SoftWatch [...]
By
PharmaOutlet
Contributed by Merrill Matthews Jr., Ph.D. ANSWERING THE INDUSTRY’S CRITICS: PRICES [...]
Contributed by Merrill Matthews Jr., Ph.D. ANSWERING THE INDUSTRY’S CRITICS: PRICES [...]
By
Raise Your Voice: Letters
RAISE your voice LETTERS Asynchronous Discussions Online asynchronous discussions provide [...]
RAISE your voice LETTERS Asynchronous Discussions Online asynchronous discussions provide [...]
By
Letter from the Editor
PharmaVOICE THE FORUM FOR THE INDUSTRY EXECUTIVE Volume 3 . [...]
PharmaVOICE THE FORUM FOR THE INDUSTRY EXECUTIVE Volume 3 . [...]
By
Taren Grom, Editor
On The Cover
Regulatory Submissions: Improving the Process
BY TAREN GROM IMPROVING E-STRATEGIES The inability to effectively manage complex submission documentation for new drug applications (NDAs) and other regulated dossiers is a major factor in slowing the time it takes to bring a product to market. These delays cost the lifescience industry millions in potential revenue. Electronic submissions can speed the process, but [...]
BY TAREN GROM IMPROVING E-STRATEGIES The inability to effectively manage complex submission documentation for new drug applications (NDAs) and other regulated dossiers is a major factor in slowing the time it takes to bring a product to market. These delays cost the lifescience industry millions in potential revenue. Electronic submissions can speed the process, but [...]
By
Taren Grom, Editor
Features
Alan Holmer — The Industry’s Champion
THE INDUSTRY’S CHAMPION BY KIM RIBBINK After a weighty career in politics and the law, and now seven years into his leadership position at the Pharmaceutical Research and Manufacturers of America, Alan F. Holmer is positioning the organization to address criticisms of the industry and convey to the world at large the benefits that drug [...]
THE INDUSTRY’S CHAMPION BY KIM RIBBINK After a weighty career in politics and the law, and now seven years into his leadership position at the Pharmaceutical Research and Manufacturers of America, Alan F. Holmer is positioning the organization to address criticisms of the industry and convey to the world at large the benefits that drug [...]
By
The Shifting Relationship Between Pharmaceutical Companies and Suppliers
The shifting relationship between pharmaceutical company and supplier: Are partnerships in peril? Fundamental aspects of the supplier/client relationship are changing. At the extreme these changes could threaten the very relationship; at the minimum these changes will require a modification in the way business is conducted. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE,RICHARD B.VANDERVEER,PH.D., CHAIRMAN AND CEO [...]
The shifting relationship between pharmaceutical company and supplier: Are partnerships in peril? Fundamental aspects of the supplier/client relationship are changing. At the extreme these changes could threaten the very relationship; at the minimum these changes will require a modification in the way business is conducted. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE,RICHARD B.VANDERVEER,PH.D., CHAIRMAN AND CEO [...]
By
From the Bedside to the Sales Side
FROM BEDSIDE to the SALES SIDE Making the Switch from PATIENT CARE to SALES and MARKETING BY ELISABETH PENA A more stable lifestyle, an outlet for creativity, and the ability to impact a larger number of patients are some of the reasons a growing number of healthcare professionals are making the move from the bedside [...]
FROM BEDSIDE to the SALES SIDE Making the Switch from PATIENT CARE to SALES and MARKETING BY ELISABETH PENA A more stable lifestyle, an outlet for creativity, and the ability to impact a larger number of patients are some of the reasons a growing number of healthcare professionals are making the move from the bedside [...]
By
The Change Managers
The Change Managers BY DENISE MYSHKO COMPANIES ARE FINDING THAT USING behavioral science IS AN EFFECTIVE WAY TO MOTIVATE EMPLOYEES, DOCTORS, AND PATIENTS TO CHANGE INGRAINED BEHAVIORS. ABOVE ALL, AS SOME PHARMA COMPANIES HAVE FOUND, BEHAVIORAL MANAGEMENT CAN INCREASE PATIENT COMPLIANCE. QUOTE: By applying tried-and-true behavior change techniques to the conversation between the constituents — [...]
The Change Managers BY DENISE MYSHKO COMPANIES ARE FINDING THAT USING behavioral science IS AN EFFECTIVE WAY TO MOTIVATE EMPLOYEES, DOCTORS, AND PATIENTS TO CHANGE INGRAINED BEHAVIORS. ABOVE ALL, AS SOME PHARMA COMPANIES HAVE FOUND, BEHAVIORAL MANAGEMENT CAN INCREASE PATIENT COMPLIANCE. QUOTE: By applying tried-and-true behavior change techniques to the conversation between the constituents — [...]
By
Bring in the Middlemen
Third-party consultants are an enduring part of the business landscape. These independent mediators can HELP MANAGE THE RELATIONSHIP BETWEEN CLIENTS AND SUPPLIERS, creating a MORE EFFECTIVE AND LONG-LASTING PARTNERSHIP. BY KIM RIBBINK OUTSOURCING is a way of life for the pharmaceutical industry. From the early stages of a potential product’s life cycle, through launch, and [...]
Third-party consultants are an enduring part of the business landscape. These independent mediators can HELP MANAGE THE RELATIONSHIP BETWEEN CLIENTS AND SUPPLIERS, creating a MORE EFFECTIVE AND LONG-LASTING PARTNERSHIP. BY KIM RIBBINK OUTSOURCING is a way of life for the pharmaceutical industry. From the early stages of a potential product’s life cycle, through launch, and [...]
By
Kim Ribbink
